Position in KRYS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$4,628,835
+$3,206,676 QoQ
Shares Held
17,919
+97.4% QoQ
Ownership
0.061%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KRYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ZACKS INVESTMENT MANAGEMENT holds $33,185,332 across 8 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
55,052 | $27,345,979 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
32,627 | $2,553,715 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
8,417 | $2,533,769 | |
| 4 | AUPH |
Aurinia Pharmaceuticals Inc.
|
36,687 | $622,578 | |
| 5 | LCTX |
Lineage Cell Therapeutics, Inc.
|
42,084 | $55,130 | |
| 6 | AGEN |
Agenus Inc
|
10,550 | $32,283 | |
| 7 | INO |
Inovio Pharmaceuticals, Inc.
|
26,435 | $29,078 | |
| 8 | GERN |
Geron Corp
|
10,000 | $12,800 |
All Filings in KRYS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,628,835 | 17,919 | Shares | Sole | 2026-05-14 | |
| 2024-12-31 | $1,422,159 | 9,078 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,719,637 | 9,447 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,642,292 | 8,943 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,428,599 | 8,029 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||